The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
Authors
Keywords
-
Journal
Neurotherapeutics
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-04
DOI
10.1007/s13311-020-00878-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus
- (2019) Silvia Poggini et al. NEURAL PLASTICITY
- Metformin exerts antidepressant effects by regulated DNA hydroxymethylation
- (2019) Yufan Wang et al. Epigenomics
- Protective role of metformin against methamphetamine induced anxiety, depression, cognition impairment and neurodegeneration in rat: The role of CREB/BDNF and Akt/GSK3 signaling pathways
- (2019) Saghar Keshavarzi et al. NEUROTOXICOLOGY
- Prognosis and improved outcomes in major depression: a review
- (2019) Christoph Kraus et al. Translational Psychiatry
- Cytokine Research in Depression: Principles, Challenges, and Open Questions
- (2019) Hubertus Himmerich et al. Frontiers in Psychiatry
- Novel Neuroimmunologic Therapeutics in Depression: A Clinical Perspective on What We Know So Far
- (2019) Michael Roman et al. BRAIN BEHAVIOR AND IMMUNITY
- Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis
- (2019) Jia Jia Liu et al. MOLECULAR PSYCHIATRY
- Metformin ameliorates stress-induced depression-like behaviors via enhancing the expression of BDNF by activating AMPK/CREB-mediated histone acetylation
- (2019) Wenting Fang et al. JOURNAL OF AFFECTIVE DISORDERS
- Metformin improves obesity-associated inflammation by altering macrophages polarization
- (2018) Yuanyuan Jing et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Metformin potentiates cognitive and antidepressant effects of fluoxetine in rats exposed to chronic restraint stress and high fat diet: potential involvement of hippocampal c-Jun repression
- (2018) Sara A. Khedr et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Anti-inflammatory effects of Metformin improve the neuropathic pain and locomotor activity in spinal cord injured rats: introduction of an alternative therapy
- (2018) Khashayar Afshari et al. SPINAL CORD
- Brain-Derived Neurotrophic Factor and Major Depressive Disorder: Evidence from Meta-Analyses
- (2018) Taro Kishi et al. Frontiers in Psychiatry
- The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
- (2018) Sahar Mohamed El-Haggar et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer’s disease: Systematic Review and Meta-Analysis
- (2018) Ada Ng et al. Scientific Reports
- Effect of Agomelatine and Fluoxetine on HAM-D Score, Serum Brain-Derived Neurotrophic Factor, and Tumor Necrosis Factor-α Level in Patients With Major Depressive Disorder With Severe Depression
- (2017) Keshav Gupta et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Neural Substrates of Depression and Resilience
- (2017) Ming-Hu Han et al. Neurotherapeutics
- Metformin – a Future Therapy for Neurodegenerative Diseases
- (2017) Magdalena Markowicz-Piasecka et al. PHARMACEUTICAL RESEARCH
- Insulin-like growth factor-1: a possible marker for emotional and cognitive disturbances, and treatment effectiveness in major depressive disorder
- (2017) Oleg A. Levada et al. Annals of General Psychiatry
- Inflammation and depression: a causal or coincidental link to the pathophysiology?
- (2017) Brian E. Leonard ACTA NEUROPSYCHIATRICA
- Experimental medication treatment approaches for depression
- (2017) D F Ionescu et al. Translational Psychiatry
- Anti-Inflammatory Effects of Metformin Irrespective of Diabetes StatusNovelty and Significance
- (2016) Amy R. Cameron et al. CIRCULATION RESEARCH
- Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study
- (2016) Martina Balestri et al. JOURNAL OF AFFECTIVE DISORDERS
- Immunomodulatory effects of fluoxetine: A new potential pharmacological action for a classic antidepressant drug?
- (2016) María Emilia Di Rosso et al. PHARMACOLOGICAL RESEARCH
- Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users
- (2016) Mariska Bot et al. PSYCHONEUROENDOCRINOLOGY
- PIOGLITAZONE ADJUNCTIVE THERAPY FOR DEPRESSIVE EPISODE OF BIPOLAR DISORDER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
- (2015) Atefeh Zeinoddini et al. DEPRESSION AND ANXIETY
- Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial
- (2015) Amirhossein Gougol et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect
- (2015) Yoshifumi Saisho Endocrine Metabolic & Immune Disorders-Drug Targets
- The role of metformin on vitamin B12 deficiency: a meta-analysis review
- (2014) Mitra Niafar et al. Internal and Emergency Medicine
- Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture
- (2014) Ewa Obuchowicz et al. Pharmacological Reports
- Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis
- (2014) Zhongquan Zhao et al. PLoS One
- Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors
- (2014) David Baumeister et al. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
- Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells
- (2013) Emelie Karnevi et al. BMC CANCER
- Rational site-directed pharmacotherapy for major depressive disorder
- (2013) Pierre Blier INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
- (2013) C. N. Haile et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
- (2013) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)
- (2013) M L Molendijk et al. MOLECULAR PSYCHIATRY
- Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications
- (2013) J.C. Felger et al. NEUROSCIENCE
- Alterations of Serum Levels of BDNF-Related miRNAs in Patients with Depression
- (2013) You-Jie Li et al. PLoS One
- Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment
- (2012) Mauro Garcia-Toro et al. BMC Psychiatry
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
- (2012) Charles L. Raison et al. JAMA Psychiatry
- Escitalopram reduces circulating pro-inflammatory cytokines and improves depressive behavior without affecting sleep in a rat model of post-cardiac infarct depression
- (2011) Thierno Madjou Bah et al. BEHAVIOURAL BRAIN RESEARCH
- Role of vascular endothelial growth factor in adult hippocampal neurogenesis: Implications for the pathophysiology and treatment of depression
- (2011) Neil M. Fournier et al. BEHAVIOURAL BRAIN RESEARCH
- Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study
- (2009) Pierre Blier et al. AMERICAN JOURNAL OF PSYCHIATRY
- Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial
- (2009) Shahin Akhondzadeh et al. DEPRESSION AND ANXIETY
- Meta-analysis of the placebo response in antidepressant trials
- (2009) Winfried Rief et al. JOURNAL OF AFFECTIVE DISORDERS
- Fluoxetine Versus Placebo in Preventing Relapse of Major Depression in Children and Adolescents
- (2008) G. J. Emslie et al. AMERICAN JOURNAL OF PSYCHIATRY
- Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study
- (2008) Fabiano G. Nery et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search